WEB_Etoricoxib T90mg

ETORICOXIB Arcoxia™Ac 90 milligrams



Generic Name: ETORICOXIB
Brand Name: Arcoxia™Ac
Dosage Strength: 90 milligrams
Dosage Form: Tablet


(Indication) Acute and chronic treatment of the signs and symptoms of osteoarthritis (OA) and rheumatoid arthritis (RA); treatment of ankylosing spondylitis (AS); treatment of acute gouty arthritis; relief of acute pain; treatment of primary dysmenorrhea; treatment of moderate to severe acute post-operative pain associated with dental surgery; treatment of moderate to severe acute post-operative pain associated with abdominal gynecological surgery.

The decision to prescribe a selective COX-2 inhibitor should be based on an assessment of the individual patient's overall risks



Rheumatoid Arthritis: The recommended dose is 90 mg once daily.
Ankylosing Spondylitis: 
The recommended dose is 90 mg once daily.
Acute Pain: 
For acute pain conditions, the recommended dose is 90 mg once daily.

ETORICOXIB (ARCOXIA) should be used only for the acute symptomatic period, limited to a maximum of 8 days treatment.

Post-Operative Dental Pain: The recommended dose is 90 mg once daily.

Post-Operative Gynecological Pain: The recommended dose is 90 mg once daily.

As the cardiovascular risks of selective COX-2 inhibitors may increase with dose and duration of exposure, the shortest duration possible and the lowest effective daily dose should be used. The patient's need for symptomatic relief and response to therapy should be re-evaluated periodically

Elderly, Gender, Race: No dosage adjustment in ETORICOXIB (ARCOXIA) is necessary for the elderly or based on gender or race.


Hypersensitivity to etoricoxib or to any of the excipients. Active peptic ulceration or active gastro-intestinal (GI) bleeding; patients who have experienced bronchospasm, acute rhinitis, nasal polyps, angioneurotic oedema, urticaria, or allergic-type reactions after taking acetylsalicylic acid or NSAIDS including COX-2 (cyclooxygenase-2) inhibitors; severe hepatic dysfunction (serum albumin <25g/l or Child-Pugh score≥10); estimated renal creatinine clearance <30 mL/min; children and adolescents under 16 years of age; inflammatory bowel disease; congestive heart failure (NYHA II-IV); patients with hypertension whose blood pressure has not been adequately controlled; established ischemic heart disease, peripheral arterial disease and/or cerebrovascular disease.

(Precautions) Use at the shortest possible duration & the lowest effective daily dose to avoid CV risk. Not a substitute for aspirin for CV prophylaxis. Patients at risk of CV events (HTN, Hyperlipidemia, DM, smoking), w/ peripheral arterial disease, or w/ preexisting edema, impaired renal function, HTN or uncompensated heart failure or cirrhosi; considerable dehydratio. History of GI perforation, ulcers & bleeding. Elderly over 65 yrs.

(Adverse Reactions) Asthenia/fatigue, dizziness, lower extremity edema, HTN, dyspepsia, heartburn, nausea, increased ALT & AST, Thrombocytopenia, hypersensitivty reactions including anaphylactic/anaphylactoid reactions including shock; hyperkalemia, anxiety, insomia, confusion, hallucinations, depression, restlessness; dysgeusia, somnolence, blurred vision, CHF, palpitations, angina, arrythmia, hypertensive crisis, bronchospasm, abdominal pain, oral ulcers, peptic ulcer including perforation or bleeding (elderly), vomiting, diarrhea, hepatitis, jaundice; hepatic failure, angioedema, pruritus, erythema, rash, Stevens-Johnson syndrome, toxic epidermal necrolysis, urticaria; fixed-drug eruption, renal insufficiency including renal failure.

Disclaimer: The contents of this site are for information purposes only and should not be construed as a susbtitute for professional medical advice. For diagnosis, treatment and prescription, consult your physician and other healthcare providers. Carefully read all product labels and packaging prior to use.


There are no reviews yet.

Be the first to review “ETORICOXIB Arcoxia™Ac 90 milligrams”

Your email address will not be published. Required fields are marked *